Sunitha Nallur

Maastricht University — Netherlands

Biochemistry, Genetics and Molecular Biology · Life Sciences

18h-index1.9kcitations59works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MicroRNA in disease regulation(23), Cancer-related molecular mechanisms research(16), RNA modifications and cancer(14), RNA Research and Splicing(8), Nutrition, Genetics, and Disease(8)

Publications59 total

Supplementary Figure 1 from A <i>Let-7</i> MicroRNA SNP in the <i>KRAS</i> 3′UTR Is Prognostic in Early-Stage Colorectal Cancer
2023Open Access
Supplementary Figure 1 from A <i>Let-7</i> MicroRNA SNP in the <i>KRAS</i> 3′UTR Is Prognostic in Early-Stage Colorectal Cancer
2023Open Access
Data from A <i>Let-7</i> MicroRNA SNP in the <i>KRAS</i> 3′UTR Is Prognostic in Early-Stage Colorectal Cancer
2023Open Access
Supplementary Figure Legend from A <i>Let-7</i> MicroRNA SNP in the <i>KRAS</i> 3′UTR Is Prognostic in Early-Stage Colorectal Cancer
2023Open Access
Supplementary Figure Legend from A <i>Let-7</i> MicroRNA SNP in the <i>KRAS</i> 3′UTR Is Prognostic in Early-Stage Colorectal Cancer
2023Open Access
Data from A <i>Let-7</i> MicroRNA SNP in the <i>KRAS</i> 3′UTR Is Prognostic in Early-Stage Colorectal Cancer
2023Open Access
Supplementary Figure 1, Tables 1-4 from A SNP in a <i>let-7</i> microRNA Complementary Site in the <i>KRAS</i> 3′ Untranslated Region Increases Non–Small Cell Lung Cancer Risk
2023Open Access
Supplementary Figure 1 from A <i>KRAS</i>-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk
2023Open Access
Data from A SNP in a <i>let-7</i> microRNA Complementary Site in the <i>KRAS</i> 3′ Untranslated Region Increases Non–Small Cell Lung Cancer Risk
2023Open Access
Supplementary Table 1 from A <i>KRAS</i>-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk
2023Open Access
Supplementary Table 1 from A Conserved RAS/Mitogen-Activated Protein Kinase Pathway Regulates DNA Damage–Induced Cell Death Postirradiation in Radelegans
2023Open Access
Supplementary Figure 2 from A <i>KRAS</i>-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk
2023Open Access
Supplementary Figure 1 from A <i>KRAS</i>-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk
2023Open Access
Supplementary Table 2 from A <i>KRAS</i>-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk
2023Open Access
Supplementary Figure 2 from A <i>KRAS</i>-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk
2023Open Access
Data from A <i>KRAS</i>-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk
2023Open Access
Data from A Conserved RAS/Mitogen-Activated Protein Kinase Pathway Regulates DNA Damage–Induced Cell Death Postirradiation in Radelegans
2023Open Access
Supplementary Table 1 from A <i>KRAS</i>-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk
2023Open Access
Supplementary Table 1 from A Conserved RAS/Mitogen-Activated Protein Kinase Pathway Regulates DNA Damage–Induced Cell Death Postirradiation in Radelegans
2023Open Access
Data from A Conserved RAS/Mitogen-Activated Protein Kinase Pathway Regulates DNA Damage–Induced Cell Death Postirradiation in Radelegans
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Joanne B. Weidhaas(47), Frank J. Slack(29), Trupti Paranjape(28), Daniel Zelterman(24), Elena Ratner(19), Lena J. Chin(15), Marta Boeke(13), Cory Pelletier(13), Pei Hui(13), Peter E. Schwartz(13), Alessandro D. Santin(13), Renata Tassi(12), Rachel Barnett(11), Rachel Blitzblau(11), Andrew K. Godwin(11), Herbert Yu(11), Ellen Matloff(11), Harvey A. Risch(10), Thomas F. Rutherford(10), Michael J. Kerin(9)